Resources
Treatment
Access the below resources for information and support as you prepare to administer ZOLGENSMA.
Before treatment
Refer patients for treatment
To locate a treatment center that can administer ZOLGENSMA: Email treatments@curesma.org or contact the MDA Resource Center
at 1-833-ASK-MDA1 or resourcecenter@mdausa.org
Novartis Gene Therapies is offering the Novartis Gene Therapies Laboratory Program to assist with genetic and anti-AAV9 antibody testing. For more information, please contact your Novartis Gene Therapies Regional Account Associate Director or call the OneGene Program® at 1-855-441-GENE (4363)
ZOLGENSMA Prescription and Patient Consent Forms
Formulario de Consentimiento del Pacient
A Spanish language Patient Consent Form for families who are better served by Spanish resources. A separate Prescription Form will still be required.